Analysts say the adoption of GLP-1 drugs, the expansion of AI and the growth of multi-billion-dollar M&A deals chart an unpredictable path for the industry this year.

Molson Coors has acquired an 8.5% stake in British drinks company Fever Tree in a £71m deal that enables the mixer brand to ...

Wells Fargo analyst Christopher Carey maintained a Buy rating on Molson Coors (TAP – Research Report) yesterday and set a price target of ...

Kromek Group left investors cheering this week as it unmasked a road to profitability via a deal with Siemens Healthineers.

Molson Coors Beverage Company has announced a strategic partnership with Fever-Tree in the US, aiming to fuel its ...

The Coors Light manufacturer’s 8.5% stake in the nonalcoholic carbonated mixer, worth $89 million, further builds on its long ...

Shares of Fevertree Drinks surged almost 24% yesterday after Molson Coors took an 8.5% stake in a $88m deal that gives the ...

CLEANING toilets and selling paraffin isn’t the usual path to becoming a CEO. But that was the route for Neil Clifford, who ...

As part of the agreement, the beer giant will manage the sales, distribution and production of Fevertree’s products in the US ...

By Shashwat Awasthi (Reuters) -Shares of Fevertree Drinks surged almost 24% after Molson Coors' took an 8.5% stake in the ...

The majority owner of the new National Women's Soccer League team in Denver says there are plans to build a dedicated soccer stadium for the club. The league formally announced on Thursday that ...

Molson Coors Beverage Company and Fevertree Drinks plc (OTCPK:FQVTF) (OTCPK:FQVTY) announced a strategic partnership that ...